CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT)

CUSIP: 218352102

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
106,815,676
Total 13F shares
76,610,306
Share change
-453,762
Total reported value
$2,668,589,112
Put/Call ratio
342%
Price per share
$34.80
Number of holders
383
Value change
-$117,760,200
Number of buys
164
Number of sells
247

Security key

218352102

Report period

Q4 2025

Institutions

383

Top holders

10

Top shareholders of CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F 13D/G
Company
11%
from 13D/G
12,047,830
$1,001,295,112 30 Sep 2025
VANGUARD GROUP INC
13F
Company
8.9%
9,537,071
$792,625,970 30 Sep 2025
13F
INGALLS & SNYDER LLC
13F 13D/G
Company
6.8%
from 13D/G
7,697,984
$639,779,000 30 Sep 2025
RENAISSANCE TECHNOLOGIES LLC
13F 13D/G
Company
5.5%
from 13D/G
6,089,347
$506,085,629 30 Sep 2025
Joseph K. Belanoff
13D/G
6.3%
6,822,335
$499,599,592 $0 31 Dec 2024
Parallel Advisors, LLC
13F
Company
3.6%
3,871,452
$321,756,376 30 Sep 2025
13F
STATE STREET CORP
13F
Company
2.8%
2,970,400
$246,869,944 30 Sep 2025
13F
FMR LLC
13F
Company
2.1%
2,201,938
$183,003,047 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
1,934,272
$161,530,218 30 Sep 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.8%
1,892,448
$157,284,888 30 Sep 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
1.4%
1,507,209
$125,264,121 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
1.1%
1,186,978
$98,649,984 30 Sep 2025
13F
Clearbridge Investments, LLC
13F
Company
1.1%
1,161,828
$96,559,510 30 Sep 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1%
1,070,281
$88,951,054 30 Sep 2025
13F
TD ASSET MANAGEMENT INC
13F
Company
0.9%
956,136
$79,464,463 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.8%
849,864
$70,632,217 30 Sep 2025
13F
Epoch Investment Partners, Inc.
13F
Company
0.79%
847,104
$70,402,813 30 Sep 2025
13F
Cerity Partners LLC
13F
Company
0.71%
758,426
$63,032,785 30 Sep 2025
13F
Invesco Ltd.
13F
Company
0.69%
732,583
$60,884,974 30 Sep 2025
13F
FIRST TRUST ADVISORS LP
13F
Company
0.67%
720,224
$59,857,775 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
0.6%
642,326
$53,383,715 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
0.56%
601,499
$49,990,559 30 Sep 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.55%
584,098
$48,544,385 30 Sep 2025
13F
Boston Trust Walden Corp
13F
Company
0.53%
562,261
$46,729,511 30 Sep 2025
13F
UBS Group AG
13F
Company
0.51%
549,938
$45,705,347 30 Sep 2025
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.49%
526,602
$43,765,892 30 Sep 2025
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.49%
521,500
$43,341,867 30 Sep 2025
13F
FRANKLIN RESOURCES INC
13F
Company
0.47%
500,057
$41,559,737 30 Sep 2025
13F
Synergy Asset Management, LLC
13F
Company
0.47%
506,856
$39,614,826 30 Sep 2025
13F
Checkpoint Capital L.P.
13F
Company
0.37%
392,331
$32,606,629 30 Sep 2025
13F
Pacer Advisors, Inc.
13F
Company
0.37%
390,559
$32,459,358 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.36%
389,086
$32,336,938 30 Sep 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.36%
383,060
$31,837,000 30 Sep 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.35%
369,869
$30,739,813 30 Sep 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.35%
369,388
$30,699,837 30 Sep 2025
13F
PUBLIC SECTOR PENSION INVESTMENT BOARD
13F
Company
0.34%
365,838
$30,404,796 30 Sep 2025
13F
JUPITER ASSET MANAGEMENT LTD
13F
Company
0.33%
350,929
$29,165,709 30 Sep 2025
13F
FAS Wealth Partners, Inc.
13F
Company
0.29%
308,318
$25,624,309 30 Sep 2025
13F
Bridgewater Associates, LP
13F
Company
0.29%
305,946
$25,427,172 30 Sep 2025
13F
Legal & General Group Plc
13F
Company
0.27%
286,800
$23,835,948 30 Sep 2025
13F
BRAUN STACEY ASSOCIATES INC
13F
Company
0.26%
280,664
$23,325,985 30 Sep 2025
13F
Aberdeen Group plc
13F
Company
0.24%
259,077
$21,531,889 30 Sep 2025
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.22%
239,812
$20,204,161 30 Sep 2025
13F
BROWN CAPITAL MANAGEMENT LLC
13F
Company
0.22%
240,047
$19,950,306 30 Sep 2025
13F
EMERALD ADVISERS, LLC
13F
Company
0.22%
232,452
$19,319,086 30 Sep 2025
13F
BURNEY CO/
13F
Company
0.22%
230,765
$19,178,839 30 Sep 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.21%
222,376
$18,481,670 30 Sep 2025
13F
COOKSON PEIRCE & CO INC
13F
Company
0.2%
211,305
$17,561,559 30 Sep 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.19%
202,729
$16,848,809 30 Sep 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.18%
188,218
$15,642,748 30 Sep 2025
13F

Institutional Holders of CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) as of Q4 2025

As of 31 Dec 2025, CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) was held by 383 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 76,610,306 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, Parallel Advisors, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, DIMENSIONAL FUND ADVISORS LP, and MORGAN STANLEY. This page lists 383 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
424
Q4 2025 holders
383
Holder diff
-41
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .